Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aquinox Pharmaceuticals Inc (AQXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7954
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company’s lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a regualting component of the PI3K pathway. Its discovery platform is based on the screening of a natural product library of compounds to identify potential SHIP1 activators. Aquinox undertakes clinical trials of several drugs for the treatment of chronic obstructive pulmonary disease, bladder pain syndrome interstitial cystitis, allergic asthma and atopic dermatitis, among others. The company has operations in Canada and the US. Aquinox is headquartered in Vancouver, British Columbia, Canada.

Aquinox Pharmaceuticals Inc (AQXP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Aquinox Pharma Raises US$18 Million In Series C Financing 10
Licensing Agreements 11
Astellas Pharma Enters into Licensing Agreement with Aquinox Pharma 11
Equity Offering 12
Aquinox Pharma Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 12
Aquinox Pharma Plans to Raise up to USD171.4 Million in Public Offering of Shares 13
Aquinox Pharma Raises USD57.7 Million in Public Offering of Shares 14
Aquinox Pharma Raises USD98 Million in Public Offering of Shares 16
Aquinox Pharma to Raise USD25 Million in Public Offering of Shares 17
Aquinox Pharma Completes IPO For US$53 Million 18
Aquinox Pharmaceuticals Inc – Key Competitors 20
Aquinox Pharmaceuticals Inc – Key Employees 21
Aquinox Pharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 08, 2018: Aquinox Pharmaceuticals announces second quarter 2018 financial results 23
May 08, 2018: Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results 25
Mar 12, 2018: Aquinox Pharmaceuticals Announces Year End 2017 Financial Results 27
Aug 08, 2017: Aquinox Pharmaceuticals Announces Second Quarter 2017 Financial Results 28
May 09, 2017: Aquinox Pharmaceuticals Announces First Quarter 2017 Financial Results 30
Mar 09, 2017: Aquinox Pharmaceuticals Announces Year End 2016 Financial Results 31
Corporate Communications 33
Mar 27, 2017: Aquinox Announces Appointment of Dr. Kelvin Neu and Dr. Richard Levy to Board of Directors 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aquinox Pharma Raises US$18 Million In Series C Financing 10
Astellas Pharma Enters into Licensing Agreement with Aquinox Pharma 11
Aquinox Pharma Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 12
Aquinox Pharma Plans to Raise up to USD171.4 Million in Public Offering of Shares 13
Aquinox Pharma Raises USD57.7 Million in Public Offering of Shares 14
Aquinox Pharma Raises USD98 Million in Public Offering of Shares 16
Aquinox Pharma to Raise USD25 Million in Public Offering of Shares 17
Aquinox Pharma Completes IPO For US$53 Million 18
Aquinox Pharmaceuticals Inc, Key Competitors 20
Aquinox Pharmaceuticals Inc, Key Employees 21
Aquinox Pharmaceuticals Inc, Other Locations 22

List of Figures
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Greenyard NV:企業の戦略・SWOT・財務分析
    Greenyard NV - Strategy, SWOT and Corporate Finance Report Summary Greenyard NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422)-医療機器分野:企業M&A・提携分析
    Summary Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company’s products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’ …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • KLA-Tencor Corporation:戦略・SWOT・企業財務分析
    KLA-Tencor Corporation - Strategy, SWOT and Corporate Finance Report Summary KLA-Tencor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • TBC Corp:企業の戦略・SWOT・財務分析
    TBC Corp - Strategy, SWOT and Corporate Finance Report Summary TBC Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Zhejiang Sunflower Light Energy Science & Technology LLC (300111):電力:M&Aディール及び事業提携情報
    Summary Zhejiang Sunflower Light Energy Science & Technology LLC (Sunowe Solar) is an alternative energy company that produces and sells solar energy battery and components. The company’s products include polycrystalline silicon wafer, photovoltaic modules, and photovoltaic cells. Its photovoltaic c …
  • Laurus Labs Ltd (LAURUSLABS):製薬・医療:M&Aディール及び事業提携情報
    Summary Laurus Labs Ltd (Laurus Labs) is a drug development company that manufactures active pharmaceutical ingredients. The company develops products through its business divisions such as laurus generics, ingredients and synthesis. It offers active pharmaceutical ingredients and intermediates for …
  • Netmedia S.A.:企業の戦略・SWOT・財務分析
    Netmedia S.A. - Strategy, SWOT and Corporate Finance Report Summary Netmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pt Indofood Sukses Makmur Tbk:企業の戦略・SWOT・財務分析
    Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hey-Song Corporation:戦略・SWOT・企業財務分析
    Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report Summary Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AMC Networks Inc.:企業の戦略・SWOT・財務情報
    AMC Networks Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Networks Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AltaGas Ltd (ALA):石油・ガス:M&Aディール及び事業提携情報
    Summary AltaGas Ltd (AltaGas) is an energy utility. The company undertakes activities related to extraction, transmission, distribution and storage of natural gas. AltaGas generates electricity utilizing diverse fuel sources, including wind, run-of-river hydro, geothermal and gas-fired generation pl …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lycatel Services Limited:企業の戦略的SWOT分析
    Lycatel Services Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Kingboard Laminates Holdings Limited (1888):企業の財務・戦略的SWOT分析
    Kingboard Laminates Holdings Limited (1888) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • S.C. Hidroelectrica SA:企業の戦略的SWOT分析
    S.C. Hidroelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Satrec Initiative Co., Ltd.:企業の戦略・SWOT・財務分析
    Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fuji Seal International Inc.:企業の戦略・SWOT・財務情報
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆